• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Plasma levels of ethionamide and prothionamide in a volunteer following intravenous and oral dosages.

作者信息

Jenner P J, Smith S E

出版信息

Lepr Rev. 1987 Mar;58(1):31-7. doi: 10.5935/0305-7518.19870004.

DOI:10.5935/0305-7518.19870004
PMID:3600145
Abstract
摘要

相似文献

1
Plasma levels of ethionamide and prothionamide in a volunteer following intravenous and oral dosages.一名志愿者静脉注射和口服乙硫异烟胺及丙硫异烟胺后的血浆水平。
Lepr Rev. 1987 Mar;58(1):31-7. doi: 10.5935/0305-7518.19870004.
2
[Determination of prothionamide and ethionamide and their sulfoxides in blood plasma].[血浆中丙硫异烟胺、乙硫异烟胺及其亚砜的测定]
Arzneimittelforschung. 1972 Jun;22(6):1027-31.
3
Ethionamide, prothionamide and thiacetazone self-administration. Studies of patient compliance using isoniazid-marked formulations.乙硫异烟胺、丙硫异烟胺和氨硫脲的自我给药。使用异烟肼标记制剂对患者依从性的研究。
Lepr Rev. 1986 Mar;57(1):9-18. doi: 10.5935/0305-7518.19860003.
4
[Bacteriostatic activity of blood in single and combined use of ethionamide or prothionamide].
Probl Tuberk. 1975(5):70-3.
5
Drugs for combined therapy: experimental studies on the antileprosy activity of ethionamide and prothionamide, and a general review.
Lepr Rev. 1978 Jun;49(2):115-26. doi: 10.5935/0305-7518.19780014.
6
[Study of concentration of ethionamide and prothionamide in the blood of patients with pulmonary tuberculosis by polarographic method].[用极谱法研究肺结核患者血液中乙硫异烟胺和丙硫异烟胺的浓度]
Probl Tuberk. 1976 May(5):75-8.
7
[Application of rapid polarography with overimposed alternating current to the study of urinary elimination of ethionamide and prothionamide metabolites in humans].[叠加交流电快速极谱法在人体乙硫异烟胺和丙硫异烟胺代谢产物尿排泄研究中的应用]
Ann Pharm Fr. 1971 Sep-Oct;29(9):461-75.
8
A comparison of the blood levels and urinary excretion of ethionamide and prothionamide in man.人体内乙硫异烟胺和丙硫异烟胺的血药浓度及尿排泄情况比较。
J Antimicrob Chemother. 1984 Mar;13(3):267-77. doi: 10.1093/jac/13.3.267.
9
Disposition of prothionamide in rats and armadillos.丙硫异烟胺在大鼠和犰狳体内的处置情况。
Int J Lepr Other Mycobact Dis. 1983 Mar;51(1):54-63.
10
[Treatment of patients with pulmonary tuberculosis, complicated by peptic ulcer, with ethionamide and prothionamide].[用乙硫异烟胺和丙硫异烟胺治疗合并消化性溃疡的肺结核患者]
Probl Tuberk. 1973;51(7):67-70.

引用本文的文献

1
Prothionamide Dose Optimization Using Population Pharmacokinetics for Multidrug-Resistant Tuberculosis Patients.采用群体药代动力学优化耐多药结核病患者的丙硫异烟胺剂量。
Antimicrob Agents Chemother. 2022 Sep 20;66(9):e0189321. doi: 10.1128/aac.01893-21. Epub 2022 Aug 8.
2
MDR Tuberculosis Treatment.耐多药结核病治疗。
Medicina (Kaunas). 2022 Jan 26;58(2):188. doi: 10.3390/medicina58020188.
3
Population Pharmacokinetics and Dosing of Ethionamide in Children with Tuberculosis.结核患儿乙硫异烟胺群体药动学与剂量研究。
Antimicrob Agents Chemother. 2020 Feb 21;64(3). doi: 10.1128/AAC.01984-19.
4
EthA/R-Independent Killing of by Ethionamide.乙硫异烟胺对EthA/R的非依赖性杀伤作用
Front Microbiol. 2017 Apr 25;8:710. doi: 10.3389/fmicb.2017.00710. eCollection 2017.
5
An ethA-ethR-deficient Mycobacterium bovis BCG mutant displays increased adherence to mammalian cells and greater persistence in vivo, which correlate with altered mycolic acid composition.一株缺失 ethA-ethR 的牛型分枝杆菌卡介苗突变株表现出对哺乳动物细胞更高的黏附性和更强的体内持久性，这与改变的分枝菌酸组成相关。
Infect Immun. 2014 May;82(5):1850-9. doi: 10.1128/IAI.01332-13. Epub 2014 Feb 24.
6
Pharmacokinetics of ethionamide administered under fasting conditions or with orange juice, food, or antacids.空腹条件下或与橙汁、食物或抗酸剂一起服用时乙硫异烟胺的药代动力学。
Antimicrob Agents Chemother. 2001 Mar;45(3):810-4. doi: 10.1128/AAC.45.3.810-814.2001.
7
Effects of AIDS and gender on steady-state plasma and intrapulmonary ethionamide concentrations.艾滋病及性别对稳态血浆和肺内乙硫异烟胺浓度的影响。
Antimicrob Agents Chemother. 2000 May;44(5):1337-41. doi: 10.1128/AAC.44.5.1337-1341.2000.
8
Clinical pharmacokinetic considerations in the treatment of patients with leprosy.麻风病患者治疗中的临床药代动力学考量
Clin Pharmacokinet. 1989 Jun;16(6):365-86. doi: 10.2165/00003088-198916060-00003.